BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mowat C, Digby J, Strachan JA, McCann R, Hall C, Heather D, Carey F, Fraser CG, Steele RJC. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study. BMJ Open Gastroenterol 2019;6:e000293. [PMID: 31275586 DOI: 10.1136/bmjgast-2019-000293] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Pin-Vieito N, García Nimo L, Bujanda L, Román Alonso B, Gutierrez-Stampa MÁ, Aguilar-Gama V, Portillo I, Cubiella J. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. United European Gastroenterol J 2021;9:256-67. [PMID: 32778002 DOI: 10.1177/2050640620949714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Saw KS, Liu C, Xu W, Varghese C, Parry S, Bissett I. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis. Br J Surg 2021:znab411. [PMID: 34907419 DOI: 10.1093/bjs/znab411] [Reference Citation Analysis]
3 Digby J, Strachan JA, McCann R, Steele RJ, Fraser CG, Mowat C. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral. Ann Clin Biochem 2020;57:325-7. [PMID: 32482080 DOI: 10.1177/0004563220935622] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Anjum MR, Chalmers J, Hamid R, Rajoriya N. COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World J Gastroenterol 2021; 27(44): 7625-7648 [PMID: 34908803 DOI: 10.3748/wjg.v27.i44.7625] [Reference Citation Analysis]
5 Mowat C, Digby J, Strachan JA, McCann RK, Carey FA, Fraser CG, Steele RJ. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care. Ann Clin Biochem 2021;58:211-9. [PMID: 33334134 DOI: 10.1177/0004563220985547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Clark GR, Anderson AS, Godfrey TG, Strachan JA, Fraser CG, Steele RJ. Variation in changes in the incidence of colorectal cancer by age and association with screening uptake: an observational study. BMJ Open 2020;10:e037925. [PMID: 32963068 DOI: 10.1136/bmjopen-2020-037925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chapman CJ, Banerjea A, Humes DJ, Allen J, Oliver S, Ford A, Hardy K, Djedovic N, Logan RF, Morling JR. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer. Clin Chem Lab Med 2020:cclm-2020-1170. [PMID: 33112776 DOI: 10.1515/cclm-2020-1170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Turvill JL, Turnock D, Cottingham D, Haritakis M, Jeffery L, Girdwood A, Hearfield T, Mitchell A, Keding A. The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer. Br J Gen Pract 2021;71:e643-51. [PMID: 33798091 DOI: 10.3399/BJGP.2020.1098] [Reference Citation Analysis]
9 Högberg C, Karling P, Rutegård J, Lilja M. Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study. BMC Fam Pract 2020;21:129. [PMID: 32611307 DOI: 10.1186/s12875-020-01194-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Logan RPH, Hamilton W. Delivering better value colonoscopy: bridging the gap with FIT. Gut 2021;70:1006-7. [PMID: 33234524 DOI: 10.1136/gutjnl-2020-323118] [Reference Citation Analysis]
11 Tsapournas G, Hellström PM, Cao Y, Olsson LI. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. Scand J Gastroenterol 2020;55:184-92. [PMID: 31906738 DOI: 10.1080/00365521.2019.1708965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21:1023-1034. [PMID: 32702310 DOI: 10.1016/s1470-2045(20)30388-0] [Cited by in Crossref: 378] [Cited by in F6Publishing: 202] [Article Influence: 189.0] [Reference Citation Analysis]
13 Calanzani N, Chang A, Van Melle M, Pannebakker MM, Funston G, Walter FM. Recognising Colorectal Cancer in Primary Care. Adv Ther 2021;38:2732-46. [PMID: 33864597 DOI: 10.1007/s12325-021-01726-6] [Reference Citation Analysis]
14 Cunin L, Khan AA, Ibrahim M, Lango A, Klimovskij M, Harshen R. FIT negative cancers: A right-sided problem? Implications for screening and whether iron deficiency anaemia has a role to play. Surgeon 2021;19:27-32. [PMID: 32199773 DOI: 10.1016/j.surge.2020.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 D'Souza N, Delisle TG, Chen M, Benton SC, Abulafi M; NICE FIT Steering Committee . Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study. Br J Surg 2021;108:804-10. [PMID: 33755051 DOI: 10.1093/bjs/znaa132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RP, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM, Goddard AF. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 2021;70:2030-51. [PMID: 34497146 DOI: 10.1136/gutjnl-2021-325210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Hicks G, D'Souza N, Georgiou Delisle T, Chen M, Benton SC, Abulafi M; NICE FIT steering group. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study. Colorectal Dis 2021;23:1630-8. [PMID: 33605522 DOI: 10.1111/codi.15593] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chapman C, Thomas C, Morling J, Tangri A, Oliver S, Simpson JA, Humes DJ, Banerjea A. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham. Colorectal Dis 2020;22:679-88. [PMID: 31876975 DOI: 10.1111/codi.14944] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
19 Digby J, Strachan JA, Mowat C, Steele RJC, Fraser CG. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study. BMC Gastroenterol 2019;19:213. [PMID: 31829141 DOI: 10.1186/s12876-019-1135-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
20 Laszlo HE, Seward E, Ayling RM, Lake J, Malhi A, Stephens C, Pritchard-Jones K, Chung D, Hackshaw A, Machesney M. Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review. Br J Cancer 2021. [PMID: 34903843 DOI: 10.1038/s41416-021-01653-x] [Reference Citation Analysis]
21 Su WC, Kao WY, Chang TK, Tsai HL, Huang CW, Chen YC, Li CC, Hsieh YC, Yeh HJ, Chang CC, Wang JY. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Biosci Rep 2021;41:BSR20201930. [PMID: 33393623 DOI: 10.1042/BSR20201930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Cubiella J. Not so FAST. Commentary on the article "Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study". BMC Gastroenterol 2020;20:231. [PMID: 32690047 DOI: 10.1186/s12876-020-01322-y] [Reference Citation Analysis]
23 Nicholson BD, James T, Paddon M, Justice S, Oke JL, East JE, Shine B. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.Aliment Pharmacol Ther. 2020;52:1031-1041. [PMID: 32677733 DOI: 10.1111/apt.15969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
24 Chetcuti Zammit S, Sidhu R. Capsule endoscopy - Recent developments and future directions. Expert Rev Gastroenterol Hepatol 2021;15:127-37. [PMID: 33111600 DOI: 10.1080/17474124.2021.1840351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Bailey JA, Weller J, Chapman CJ, Ford A, Hardy K, Oliver S, Morling JR, Simpson JA, Humes DJ, Banerjea A. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation. BJS Open 2021;5:zraa056. [PMID: 33693553 DOI: 10.1093/bjsopen/zraa056] [Reference Citation Analysis]
26 Högberg C, Gunnarsson U, Jansson S, Thulesius H, Cronberg O, Lilja M. Diagnosing colorectal cancer in primary care: cohort study in Sweden of qualitative faecal immunochemical tests, haemoglobin levels, and platelet counts. Br J Gen Pract 2020;70:e843-51. [PMID: 33139332 DOI: 10.3399/bjgp20X713465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
27 Fraser CG. Use of fecal immunochemical testing in patients presenting in primary care with lower GI symptoms. CMAJ 2020;192:E377. [PMID: 32392528 DOI: 10.1503/cmaj.74717] [Reference Citation Analysis]
28 van Melle M, Yep Manzano SIS, Wilson H, Hamilton W, Walter FM, Bailey SER. Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines. Fam Pract 2020;37:606-15. [PMID: 32377668 DOI: 10.1093/fampra/cmaa043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Cripps NPJ, Mills SC, Docherty JG, Baragwanath P; Colonoscopy Sub-Committee of the Association of Coloproctology of Great Britain, Ireland. Colonoscopy at a crossroads - Which direction to take in the UK after the coronavirus pandemic? Colorectal Dis 2020. [PMID: 33350046 DOI: 10.1111/codi.15437] [Reference Citation Analysis]
30 Davies M, Teirnan J; executive committee of the Association of Coloproctology of Great Britain and Ireland. Association of Coloproctology of Great Britain and Ireland response to: "Have large increases in fast track referrals improved bowel cancer outcomes in the UK?". BMJ 2021;372:n21. [PMID: 33419732 DOI: 10.1136/bmj.n21] [Reference Citation Analysis]
31 ScotCap Clinical Leads Collaboration. Follow-up of small and diminutive colonic polyps-How to balance the risks in the COVID-19 era. Colorectal Dis 2021;23:3061-4. [PMID: 34510684 DOI: 10.1111/codi.15907] [Reference Citation Analysis]
32 Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.United European Gastroenterol J. 2020;8:559-566. [PMID: 32213041 DOI: 10.1177/2050640620913674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer 2020;20:616. [PMID: 32611328 DOI: 10.1186/s12885-020-07074-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Thompson M, O'Leary D, Heath I, Wood LF, Ellis B, Flashman K, Smart N, Nicholls J, Mortensen N, Finan P, Senapati A, Steele R, Dawson P, Hill J, Moran B; d. Have large increases in fast track referrals improved bowel cancer outcomes in UK? BMJ 2020;371:m3273. [PMID: 33172846 DOI: 10.1136/bmj.m3273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 McSorley ST, Digby J, Clyde D, Cruickshank N, Burton P, Barker L, Strachan JA, Fraser CG, Smith K, Mowat C, Winter J, Steele RJC. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care. Colorectal Dis 2021;23:1615-21. [PMID: 33064898 DOI: 10.1111/codi.15405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Pin-Vieito N, Tejido-Sandoval C, de Vicente-Bielza N, Sánchez-Gómez C, Cubiella J. Faecal immunochemical tests safely enhance rational use of resources during the assessment of suspected symptomatic colorectal cancer in primary care: systematic review and meta-analysis. Gut 2021:gutjnl-2021-324856. [PMID: 34108236 DOI: 10.1136/gutjnl-2021-324856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Almilaji O, Smith C, Surgenor S, Clegg A, Williams E, Thomas P, Snook J. Refinement and validation of the IDIOM score for predicting the risk of gastrointestinal cancer in iron deficiency anaemia. BMJ Open Gastroenterol 2020;7:e000403. [PMID: 32444424 DOI: 10.1136/bmjgast-2020-000403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
38 Maclean W, Mackenzie P, Limb C, Zahoor Z, Whyte MB, Rockall T, Benton SC, Jourdan I. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients. Colorectal Dis 2021;23:2376-86. [PMID: 34157205 DOI: 10.1111/codi.15780] [Reference Citation Analysis]
39 Hamarneh Z, Symonds EL, Kholmurodova F, Cock C. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test? J Gastroenterol Hepatol 2020;35:1002-8. [PMID: 31606908 DOI: 10.1111/jgh.14888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rodríguez-Alonso L, Rodríguez-Moranta F, Maisterra S, Botargues JM, Berrozpe A, Ruíz-Cerulla A, Suris G, Camps B, Gornals JB, Guardiola J. The EPAGE guidelines are not an effective strategy for managing colonoscopies during the COVID-19 pandemic. Gastroenterol Hepatol 2021:S0210-5705(21)00009-1. [PMID: 33545240 DOI: 10.1016/j.gastrohep.2020.11.020] [Reference Citation Analysis]
41 [DOI: 10.1101/2020.05.15.20077909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Majano SB, Lyratzopoulos G, Rachet B, de Wit NJ, Renzi C. Do presenting symptoms, use of pre-diagnostic endoscopy and risk of emergency cancer diagnosis vary by comorbidity burden and type in patients with colorectal cancer? Br J Cancer 2021. [PMID: 34741134 DOI: 10.1038/s41416-021-01603-7] [Reference Citation Analysis]
43 D'Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M;  NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut. 2020;. [PMID: 33087488 DOI: 10.1136/gutjnl-2020-321956] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
44 Maclean W, Limb C, Mackenzie P, Whyte MB, Benton SC, Rockall T, Jourdan I. Adoption of faecal immunochemical testing for 2‐week‐wait colorectal patients during the COVID‐19 pandemic: an observational cohort study reporting a new service at a regional centre. Colorectal Dis 2021;23:1622-9. [DOI: 10.1111/codi.15408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Högberg C, Gunnarsson U, Cronberg O, Thulesius H, Lilja M, Jansson S. Qualitative faecal immunochemical tests (FITs) for diagnosing colorectal cancer in patients with histories of rectal bleeding in primary care: a cohort study. Int J Colorectal Dis 2020;35:2035-40. [PMID: 32602056 DOI: 10.1007/s00384-020-03672-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]